Paradigm Biocapital Advisors as of Dec. 31, 2022
Portfolio Holdings for Paradigm Biocapital Advisors
Paradigm Biocapital Advisors holds 23 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Incyte Corporation (INCY) | 8.0 | $69M | 853k | 80.32 | |
| Biogen Idec (BIIB) | 7.8 | $66M | 239k | 276.92 | |
| Mirati Therapeutics | 6.7 | $58M | 1.3M | 45.31 | |
| Horizon Therapeutics Pub L SHS | 6.4 | $54M | 478k | 113.80 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 6.2 | $53M | 1.1M | 49.92 | |
| Miragen Therapeutics (VRDN) | 6.0 | $51M | 1.8M | 29.21 | |
| Syndax Pharmaceuticals (SNDX) | 5.8 | $50M | 2.0M | 25.45 | |
| Immunocore Hldgs Ads (IMCR) | 5.7 | $49M | 858k | 57.07 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 5.1 | $43M | 353k | 122.13 | |
| Vor Biopharma (VOR) | 5.0 | $43M | 6.4M | 6.65 | |
| United Therapeutics Corporation (UTHR) | 4.9 | $41M | 149k | 278.09 | |
| Seagen | 4.3 | $37M | 286k | 128.51 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 4.3 | $37M | 1.2M | 29.60 | |
| Argenx Se Sponsored Adr (ARGX) | 4.0 | $34M | 90k | 378.83 | |
| Akero Therapeutics (AKRO) | 3.9 | $33M | 605k | 54.80 | |
| Arcellx Common Stock (ACLX) | 3.2 | $27M | 882k | 30.98 | |
| Karuna Therapeutics Ord | 2.4 | $21M | 106k | 196.50 | |
| Arvinas Ord (ARVN) | 2.4 | $21M | 600k | 34.21 | |
| Alpine Immune Sciences (ALPN) | 2.0 | $17M | 2.3M | 7.35 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.9 | $16M | 890k | 18.30 | |
| Zai Lab Adr (ZLAB) | 1.9 | $16M | 515k | 30.70 | |
| Poseida Therapeutics I (PSTX) | 1.5 | $13M | 2.4M | 5.30 | |
| Prothena Corp SHS (PRTA) | 0.5 | $4.5M | 75k | 60.25 |
